// App-Quantinova.ai

: Simulation via instant messaging − birmingham advance (SIMBA) as a tool to bridge gaps in clinical knowledge and expectations between physicians and patients with polycystic ovary syndrome

Researchers

Presenter

  • Pavithra Sakthivel

Principal Investigators

  • Fatema Rezai

  • Carina Synn Cuen Pan

  • Jameela Sheikh

  • Harjeet Kaur

  • Catherine Cooper

  • Farah Abdelhameed

  • Francesca Pang

  • Shreya Bhatt

  • Dania Shabbir

  • Meri Davitadze

  • Helena Gleeson

  • Konstantinos Manolopoulos

  • Justin Chu

  • Michael O Reilly

  • Wiebke Arlt

  • Caroline Gillett

  • Punith Kempegowda

Medical Centers

  • University of Birmingham College of Medical and Dental Sciences, Birmingham, UK

  • Ninewells Hospital Dundee, Dundee, United Kingdom

  • Institute of Metabolism and Systems Research, University of Birmingham, College of Medical and Dental Sciences, Birmingham, United Kingdom

  • Walsall Manor Hospital, Walsall Healthcare NHS Trust, West Midlands, United Kingdom

  • University of Warwick, Coventry, United Kingdom

  • Karachi Medical and Dental College, Karachi, Pakistan

  • Georgian-American Family Medicine Clinic ’Medical House’, Georgia

  • Queen Elizabeth Hospital - Histopathology - University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom

  • Birmingham Women’s Hospital, Birmingham Women’s and Children’s NHS Foundation Trust, Birmingham, United Kingdom

  • Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, Dublin, Ireland

Locations

  • United Kingdom

  • Pakistan

  • Georgia

  • Ireland

Companies

  • N/A

Study Components

Therapeutic Area

  • Obstetrics/Gynecology

Disease

  • Polycystic Ovary Syndrome

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A